Page 14 - Morphosys News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Morphosys. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Morphosys Today - Breaking & Trending Today

MorphoSys AG Reports Outcome of Annual General Meeting 2023

EQS-News: MorphoSys AG

/ Key word: AGM/EGM

MorphoSys AG Reports Outcome of Annual General Meeting 2023

17.05.2023 / 22:01 CET/CEST

The issuer is solely responsible for the. | May 17, 2023 ....

United States , George Golumbeski , Eamonn Nolan , Michael Brosnan , Thomas Biegi , Julia Neugebauer , Jean Paul Kress , Articles Of Association , Exchange Commission , Annual General Meeting , Supervisory Boards , Management Board , Supervisory Board , Authorized Capital , Conditional Capital , Remuneration Report , Annual General , General Meeting , Executive Committee , Chief Executive Officer , Morphosy Annual Report , Morphosys Ag Stock Exchange , Press Release , Or Mor De0006632003 ,

MorphoSys Highlights Potential of Its Mid- to Late-Stage Oncology Pipeline at 2023 ASCO and EHA Annual Meetings

EQS-News: MorphoSys AG

/ Key word: Miscellaneous

MorphoSys Highlights Potential of Its Mid- to Late-Stage Oncology Pipeline at 2023 ASCO and EHA Annual Meetings

11.05.2023 / 18:39. | May 11, 2023 ....

United States , Julia Neugebauer , Eamonn Nolan , Tim Demuth , Thomas Biegi , Constellation Pharmaceuticals Inc , European Hematology Association , American Society Of Hematology Annual Meeting , Xencor Inc , American Society Of Clinical Oncology , Drug Administration , Exchange Commission , Development Officer , American Association For Cancer Research Annual Meeting , Sys Highlights Potential , Late Stage Oncology Pipeline , American Society , Clinical Oncology , Annual Meeting , Hybrid Congress , Morphosys Chief Research , American Association , Cancer Research Annual Meeting , High Risk Essential Thrombocythemia Refractory , Preliminary Results From , Advanced Solid Tumors ,

MorphoSys (OTCMKTS:MPSYF) Stock Price Up 5.6%

MorphoSys AG (OTCMKTS:MPSYF – Get Rating) rose 5.6% on Wednesday . The stock traded as high as $20.77 and last traded at $20.77. Approximately 100 shares traded hands during mid-day trading, a decline of 91% from the average daily volume of 1,063 shares. The stock had previously closed at $19.66. MorphoSys Price Performance The company […] ....

Morphosys Company Profile , Get Rating , Morphosys Daily , Otcmkts Mpsyf ,

JPMorgan raises target for Morphosys to 12 euros - 'Underweight'

U.S. bank JPMorgan raised its price target for Morphosys to 12 euros from 11 euros after the biotech company s quarterly results, but left its rating at underweight. Analyst James Gordon lowered his. | May 5, 2023 ....

James Gordon , Morphosys Ag Stock Exchange , Press Release , Owered Mor De0006632003 ,

Morphosys grows surprisingly strongly at the start of the year

After an unexpectedly strong final quarter of 2022, biotech company Morphosys has also performed surprisingly well at the start of the year. The Bavarian company s sales jumped in the first quarter.. | May 4, 2023 ....

United States , Jean Paul Kress , James Gordon , Rajan Sharma , Constellation Pharmaceuticals , Goldman Sachs , Management Board , Morphosys Ag Stock Exchange , Press Release , Irst Mor De0006632003 ,